Rotenone is widely used to model the death of dopamine neurons in Parkinson's disease both in vitro and in vivo, and the drug works via c-Jun N-terminal protein kinase (JNK) to inhibit VMAT2 [41]. The gene discussed is MAPK8; the disease is Parkinson disease.